Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
about
The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-RespondersAcquired red blood cell alloantibodies in transfused patients of 80 years or over: a 2008-2013 national haemovigilance survey.Matching for the D antigen in haematopoietic progenitor cell transplantation: definition and clinical outcomes.Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review.Antibody screening & identification in the general patient population at a tertiary care hospital in New Delhi, India.Responder individuality in red blood cell alloimmunization.Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.High-throughput Kell, Kidd, and Duffy matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry-based blood group genotyping of 4000 donors shows close to full concordance with serotyping and detects new alleles.Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity.Transfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cells.Presence of Irregular Antibody (Anti-c) in a Multitransfused Cardiac Surgery Patient.Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.Frequency of Red Cell Alloimmunization and Autoimmunization in Thalassemia Patients: A Report from Eastern India.Incidence of Red Cell Alloantibody among the Transfusion Recipients of Universiti Kebangsaan Malaysia Medical Centre.Bridging channel dendritic cells induce immunity to transfused red blood cells.Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies.Anti-M antibodies: Biphasic (reactive at room temperature and at 37°C): A case series.Frequency & specificity of RBC alloantibodies in patients due for surgery in Iran.Prevalence, specificity and risk of red blood cell alloantibodies among hospitalised Hubei Han Chinese patients.Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review.A 13-question approach to resolving serological discrepancies in the transfusion medicine laboratory.Red cell transfusion and the immune system.Association of HLA-DRB1 and HLA-DQB1 with red-blood-cell alloimmunization in the Czech population.Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence.Variation in vital signs resulting from blood component administration in adults.Measuring the influence of blood component infusion rate on recipient vital signs.Prevalence and specificity of RBC alloantibodies in the general hospitalised population in Guangxi.Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.Transfusion Service Observations: Red Blood Cell Surname-Antibody Pairings.Red cell alloimmunization & role of advanced immunohaematological support in liver transplantation.Bortezomib decreases the magnitude of a primary humoral immune response to transfused red blood cells in a murine model.Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.A novel network analysis tool to identify relationships between disease states and risks for red blood cell alloimmunization.Irradiation of Red Blood Cells and Alloimmunization.Estimating the immunogenicity of blood group antigens: a modified calculation that corrects for transfusion exposures.Consider the source: the importance of including all transfused products and exposures in red blood cell alloimmunization research.Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization.Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study).Antibody of undetermined specificity: frequency, laboratory features, and natural history.
P2860
Q27000807-F8727D04-12ED-41A3-84AD-548774A8F4B0Q33739529-6CB69F99-307D-4885-BF7F-04C7AB456B54Q33953403-3EF88C9A-4C09-4DFC-8C3D-4F21159B90DCQ34569009-B3956759-5793-437E-B0E6-C8AB420D7BF2Q34590858-85D49843-180A-42D7-A90D-4DF10C79D3A7Q34791984-19827656-253B-4ECE-902B-B8C60CD8C24DQ34792041-073EC9A5-52FF-43AB-85CD-573200F57CB3Q35171614-C0C62C46-CE6A-438B-A058-4C52DFF21776Q35219015-2245CDE0-AF3E-4073-BF3B-3F656BF48991Q35219113-9D3AE00E-41B1-4924-8CB1-D5D61FE01D7BQ35736965-20CA47C8-F30A-46A8-B481-79BADED1FDB2Q35776447-7EC37C81-A918-4DAD-A5C0-7360690ACE31Q36074678-16C79236-60A1-4B2E-8C95-02CF700CC08AQ36795125-74D8741D-7426-45AB-A1D9-91C07A02D2F9Q36949916-0E73617C-44F1-4907-A44C-928BCF3E6D6CQ37067373-3F6C6AC7-5349-4D5D-8FB2-5EEFCDBE6C3BQ37193740-FD5E199C-2057-4D79-801A-869C8BD89EC7Q37210285-2A2CB7DC-4041-4D4E-B69B-BBB08D6B60B2Q37588941-209F7B30-885F-4AB4-9291-C8FE23008668Q37984529-045A3BFB-31E5-4DCD-828F-0A932E89F4B3Q38232678-3AA58934-ED98-42E3-B4D5-226EF87A260EQ38273784-433FD2C5-27EC-4600-BFF4-3BA5616B1D5DQ39040981-177DABC4-2287-4C93-8D81-675585C73261Q39166162-C2CC7EED-DD4B-4F6F-971E-C86B9B547A7DQ39619335-D5BB199B-D45C-4CF3-814E-61EFFDD028E3Q40160876-BA70291A-9B79-44D8-9620-38B12F9610EEQ40737242-192CED81-87D4-4E91-93C1-2D67E63CD36FQ40775140-B792B2B0-9636-41E2-86F4-891094B8C347Q40787085-103BAEBB-DFD7-43F8-A808-243F2FBE7D88Q41948097-6E20C881-DDFF-4B66-8266-43044BB7409BQ43725073-E0F51D34-9F7B-4A41-84D9-D88894E034E0Q46207877-3387346B-8F06-4098-BC34-7F15E08C1472Q47210721-6F29852B-581F-40EA-BF05-6EBC0CB73729Q48366460-1C720B4A-6814-4CAA-BE5E-072C7C2A3141Q50212524-E53DCA21-D7BB-4DC6-834B-F228AD298EA9Q50236780-F32318EF-1774-4ED3-89A6-B87F2CA30EBBQ50261305-C6DC4C16-DA2F-4E98-AA7E-773BE2742D22Q50283862-6F4F8F8D-E430-4757-8BE1-CA95A0029BE7Q50435948-8F4D2D4C-1096-45E2-9022-E469774AC837Q50497090-EEDE6BBB-F23F-45BE-9CFA-8DE940C3FEEF
P2860
Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Red blood cell alloantibody fr ...... ion of male military veterans.
@en
Red blood cell alloantibody fr ...... ion of male military veterans.
@nl
type
label
Red blood cell alloantibody fr ...... ion of male military veterans.
@en
Red blood cell alloantibody fr ...... ion of male military veterans.
@nl
prefLabel
Red blood cell alloantibody fr ...... ion of male military veterans.
@en
Red blood cell alloantibody fr ...... ion of male military veterans.
@nl
P2093
P1433
P1476
Red blood cell alloantibody fr ...... ion of male military veterans.
@en
P2093
Christopher A Tormey
Gary Stack
P304
P356
10.1111/J.1537-2995.2008.01815.X
P577
2008-07-09T00:00:00Z